Kids with a rare bone cancer called Ewing sarcoma might live longer if prescribed pazopanib, a drug that blocks blood supply ...

Inhibrx Biosciences said on Thursday its experimental drug helped slow the progression of a rare and aggressive bone cancer ...

A Sarasota toddler born with a rare immune disorder can only receive a life-saving bone marrow transplant at the National ...

A new study published in the journal BMC Medicine showed that sitagliptin treatment helped preserve total femur T scores in ...

The position statement from cancer and bone societies updates recommendations from 2017 for managing bone loss and fracture ...

Learn about Bone-02, the innovative bone glue adhesive transforming fracture treatment by eliminating screws, plates, and ...

Celebrate World Osteoporosis Day 2025 with top tips to keep your bones strong, prevent fractures, and maintain long-term ...

Inhibrx Biosciences, Inc. reports strong phase 2 results for ozekibart in chondrosarcoma, with new cancer data and key ...

BERLIN -- Administering bone-modifying agents (BMAs) every 24 weeks after long-term use was a safe and effective strategy for ...

Ewing sarcoma is one of the most common bone cancers seen in children, and if it spreads, it can be deadly. One study found ...

Bone marrow aspirate concentrate (BMAC) is a common treatment for joint injuries. The invasive therapy involves extracting ...

Bent bone dysplasia (BBD) is a perinatal-lethal skeletal disorder caused by pathogenic FGFR2 mutations that disrupt bone ...